Unique features of high-density lipoproteins in the Japanese: In population and in genetic factors

Nutrients

Volumn 7, Issue 4, 2015, Pages 2359-2381

  Yokoyama, Shinji ^a  

^a CHUBU UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; CETP; Cholesterol; HDL; Japan; Keyword; Schistosoma

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; CETP PROTEIN, HUMAN;

CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); GENDER; GENE FREQUENCY; GENE MUTATION; HEREDITY; HUMAN; JAPAN; JAPANESE (PEOPLE); LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PROTEIN DEFICIENCY; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SIMULATION; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BLOOD; CORONARY DISEASE; DEFICIENCY; GENETICS; LIPID METABOLISM, INBORN ERRORS; PREVALENCE; RISK FACTOR;

SCHISTOSOMA;

ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; HUMANS; JAPAN; LIPID METABOLISM, INBORN ERRORS; PREVALENCE; RISK FACTORS;

EID: 84927925398     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7042359     Document Type: Review

References (74)

1. Ministry of Health, Labor and Welfare of Japan, National Health and Nutritional Survey. Available online: http://www.mhlw.go.jp/toukei/itiran/gaiyo/k-eisei.html (accessed on 1 January 2012). (In Japanese)
2. Worth, R.M.; Kato, H.; Rhoads, G.G.; Kagan, K.; Syme, S.L. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Mortality. Amer. J. Epidemiol. 1975, 102, 481-490.
3. Sekikawa, A.; Curb, J.D.; Ueshima, H.; El-Saed, A.; Kadowaki, T.; Abbott, R.D.; Evans, R.W.; Rodriguez, B.L.; Okamura, T.; Sutton-Tyrrell, K.; et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: A cross-sectional study. J. Am. Coll. Cardiol. 2008, 52, 417-424.
4. Sasai, K.; Okuyama-Noji, K.; Hibino, T.; Ikeuchi, R.; Sakuma, N.; Fujinami, T.; Yokoyama, S. Human cholesteryl ester transfer protein (CETP) measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cetp: Plasma CETP and lipoproteins among Japanese hypercholesterolemic patients. Clin. Chem. 1998, 44, 1466-1473.
5. Goto, A.; Sasai, K.; Suzuki, S.; Fukutomi, T.; Ito, S.; Matsushita, T.; Okamoto, M.; Suzuki, T.; Itoh, M.; Okuyama-Noji, K.; et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: A study based on coronary angiography. Atheroscelrosis 2001, 159, 153-163.
6. Yokoyama, S.; Ueshima, H.; Miida, T.; Nakamura, M.; Takata, K.; Fukukawa, T.; Goto, T.; Harada-Shiba, M.; Sano, M.; Kato, K.; et al. High-density lipoprotein levels have markedly increased over the past twenty years in Japan. J. Atheroscler. Thromb. 2014, 21, 151-160.
7. Yokoyama, S.; Yamashita, S.; Ishibashi, S.; Sone, H.; Oikawa, S.; Shirai, K.; Ohta, T.; Bujo, H.; Kobayashi, J.; Arai, H.; et al. Background to discuss guidelines for control of plasma HDL-cholesterol in Japan. J. Atheroscler. Thromb. 2012, 19, 207-212.
8. Okumura-Noji, K.; Sasai, K.; Zhan, R.; Kawaguchi, H.; Maruyama, H.; Tada, T.; Takahashi, H.; Okazaki, M.; Miida, T.; Sakuma, N.; et al. Cholesteryl ester transfer protein deficiency causes slow egg embryonation of Schistosoma japonicum. Biochem. Biophys. Res. Com. 2001, 286, 305-310.
9. Okumura-Noji, K.; Miura, Y.; Lu, R.; Asai, K.; Ohta, N.; Brindley, P.J.; Yokoyama, S. Cd36-related protein in Schistosoma japonicum: Candidate mediator of selective cholesteryl ester uptake from high-density lipoprotein for egg maturation. FASEB J. 2013, 27, 1236-1244.
10. Yokoyama, S. A potential screening factor for accumulation of cholesteyl ester transfer protein deficiency in East Asia: Schistosoma japonicum. Biochim. Biophys. Acta 2014, 1841, 495-504.
11. Sugiuchi, H.; Uji, Y.; Okabe, H.; Irie, T.; Uekama, K.; Kayahara, N.; Miyauchi, K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin. Chem. 1995, 41, 717-723.
12. Miida, T.; Nishimura, K.; Okamura, T.; Hirayama, S.; Ohmura, H.; Yoshida, H.; Miyashita, Y.; Ai, M.; Tanaka, A.; Sumino, H.; et al. Validation of homogeneous assays for HDL-cholesterol using fresh samples from healthy and diseased subjects. Atherosclerosis 2014, 233, 253-259.
13. Nakamura, M.; Yokoyama, S.; Kayamori, Y.; Iso, H.; Kitamura, A.; Okamura, T.; Kiyama, M.; Noda, H.; Nishimura, K.; Nakai, M.; et al. HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method. Clin. Chim. Acta 2015, 439, 185-190.
14. Andersson, C.; Lyass, A.; Vasan, R.S.; Massaro, J.M.; D'Agostino, R.B., Sr.; Robins, S.J. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the framingham heart study. Am. Heart J. 2014, 168, 878-883.
15. Gordon, T.; Kannel, W.B.; Castelli, W.P.; Dawber, T.R. Lipoproteins, cardiovascular disease, and death. The framingham study. Arch. Intern. Med. 1981, 141, 1128-1131
16. Preis, S.R.; Pencina, M.J.; Mann, D.M.; D'Agostino, R.B., Sr.; Savage, P.J.; Fox, C.S. Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the framingham heart study. Diabetes Care 2013, 36, 1590-1596.
17. Wilson, P.W.; Abbott, R.D.; Castelli, W.P. High density lipoprotein cholesterol and mortality. The framingham heart study. Arteriosclerosis 1988, 8, 737-741.
18. Carroll, M.D.; Lacher, D.A.; Sorlie, P.D.; Cleeman, J.I.; Gordon, D.J.; Wolz, M.; Grundy, S.M.; Johnson, C.L. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005, 294, 1773-1781.
19. Carroll, M.D.; Kit, B.K.; Lacher, D.A.; Shero, S.T.; Mussolino, M.E. Trends in lipids and lipoproteins in us adults, 1988-2010. JAMA 2012, 308, 1545-1554.
20. Yamamoto, A.; Nakamura, H.; Yasugi, T.; Mabuchi, H.; Kita, T.; Matsuzawa, Y.; Nakaya, N.; Saito, S.; Horibe, H. Current state of and recent trends in serum lipid levels in the general Japanese population. Research committee on serum lipid level survey 1990 in Japan. J. Atheroscler. Thromb. 1996, 2, 122-132.
21. Arai, H.; Yamamoto, A.; Matsuzawa, Y.; Saito, Y.; Yamada, N.; Oikawa, S.; Mabuchi, H.; Teramoto, T.; Sasaki, J.; Nakaya, N.; et al. Serum lipid survey and its recent trend in the general Japanese population in 2000. J. Atheroscler. Thromb. 2005, 12, 98-106.
22. Nakamura, H.; Arakawa, K.; Itakura, H.; Kitabatake, A.; Goto, Y.; Toyota, T.; Nakaya, N.; Nishimoto, S.; Muranaka, M.; Yamamoto, A.; et al. Primary prevention of cardiovascular disease with pravastatin in Japan (mega study): A prospective randomised controlled trial. Lancet 2006, 368, 1155-1163.
23. Matsuzaki, M.; Kita, T.; Mabuchi, H.; Matsuzawa, Y.; Nakaya, N.; Oikawa, S.; Saito, Y.; Sasaki, J.; Shimamoto, K.; Itakura, H.; et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ. J. 2002, 66, 1087-1095.
24. National Sensus 1995. Available online: http://www.stat.go.jp/data/kokusei/1995/zuhyou/ 06273.xls (accessed on 1 January 2012). (In Japanese)
25. Sasaki, J.; Kita, T.; Mabuchi, H.; Matsuzaki, M.; Matsuzawa, Y.; Nakaya, N.; Oikawa, S.; Saito, Y.; Shimamoto, K.; Kono, S.; et al. Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin. Circ. J. 2006, 70, 810-814.
26. Ko, K.W.; Ohnishi, T.; Yokoyama, S. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein. Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies. J. Biol. Chem. 1994, 269, 28206-28213.
27. Ohnishi, T.; Tan, C.; Yokoyama, S. Selective transfer of cholesteryl ester over triglyceride by human plasma lipid transfer protein between apolipoprotein-activated lipid microemulsion. Biochemistry 1994, 33, 4533-4542.
28. Qiu, X.; Mistry, A.; Ammirati, M.J.; Chrunyk, B.A.; Clark, R.W.; Cong, Y.; Culp, J.S.; Danley, D.E.; Freeman, T.B.; Geoghegan, K.F.; et al. Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat. Struct. Mol. Biol. 2007, 14, 106-113.
29. Tall, A. Plasma lipid transfer proteins. Ann. Rev. Biochem. 1995, 64, 235-257.
30. Foger, B.; Ritsch, A.; Doblinger, A.; Wessels, H.; Patsch, J.R. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 1996, 16, 1430-1436.
31. Czarnecka, H.; Yokoyama, S. Regulation of cellular cholesterol efflux by lecithin: Cholesterol acyltransferase reaction through nonspecific lipid exchange. J. Biol. Chem. 1996, 271, 2023-2028.
32. Kurasawa, T.; Yokoyama, S.; Miyake, Y.; Yamamura, T.; Yokoyama, S. Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia. J. Biochem. 1985, 98, 1499-1508.
33. Koizumi, J.; Mabuchi, H.; Yoshimura, A.; Michishita, I.; Takeda, M.; Itoh, H.; Sakai, Y.; Sakai, T.; Ueda, K.; Takeda, R. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis 1985, 58, 175-186.
34. Brown, M.L.; Inazu, A.; Hesler, C.B.; Agellon, L.B.; Mann, C.; Whitlock, M.E.; Marcel, Y.L.; Milne, R.W.; Koizumi, J.; Mabuchi, H.; et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989, 342, 448-451.
35. Inazu, A.; Jiang, X.C.; Haraki, T.; Yagi, K.; Kamon, N.; Koizumi, J.; Mabuchi, H.; Takeda, R.; Takata, K.; Moriyama, Y.; et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 1994, 94, 1872-1882.
36. Sakai, N.; Yamashita, S.; Hirano, K.; Menju, M.; Arai, T.; Kobayashi, K.; Ishigami, M.; Yoshida, Y.; Hoshino, T.; Nakajima, N.; et al. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis 1995, 114, 139-145.
37. Hirano, K.; Yamashita, S.; Nakajima, N.; Arai, T.; Maruyama, T.; Yoshida, Y.; Ishigami, M.; Sakai, N.; Kameda-Takemura, K.; Matsuzawa, Y. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 1053-1059.
38. Maruyama, T.; Yamashita, S.; Matsuzawa, Y.; Bujo, H.; Takahashi, K.; Saito, Y.; Ishibashi, S.; Ohashi, K.; Shionoiri, F.; Gotoda, T.; et al. Mutations in japanese subjects with primary hyperlipidemia-Results from the research committee of the ministry of health and welfare of Japan since 1996. J. Atheroscler. Thromb. 2004, 11, 131-145.
39. Yamashita, S.; Hirano, K.; Sakai, N.; Matsuzawa, Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim. Biophys. Acta 2000, 1529, 257-275.
40. Nagano, M.; Yamashita, S.; Hirano, K.; Takano, M.; Maruyama, T.; Ishihara, M.; Sagehashi, Y.; Kujiraoka, T.; Tanaka, K.; Hattori, H.; et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J. Atheroscler. Thromb. 2004, 11, 110-121.
41. Nagano, M.; Yamashita, S.; Hirano, K.; Ito, M.; Maruyama, T.; Ishihara, M.; Sagehashi, Y.; Oka, T.; Kujiraoka, T.; Hattori, H.; et al. Two novel missense mutations in the cetp gene in Japanese hyperalphalipoproteinemic subjects: High-throughput assay by invader assay. J. Lipid Res. 2002, 43, 1011-1018.
42. Ritsch, A.; Drexel, H.; Amann, F.W.; Pfeifhofer, C.; Patsch, J.R. Deficiency of cholesteryl ester transfer protein: Description of molecular defect and the dissociation of cholesteryl ester and triglyceride transfer in plasma. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 3433-3441.
43. Hui, S.P. Frequency and effect on plasma lipoprotein metabolism of a mutation in the cholesteryl ester transfer protein gene in the Chinese. Hokkaido J. Med. Sci. 1997, 72, 319-327.
44. Chen, D.W.; Yang, J.F.; Tang, Z.; Dong, X.M.; Feng, X.L.; Yu, S.; Chan, P. Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese. Brain Res. 2008, 1187, 52-57.
45. Hsu, L.A.; Ko, Y.L.; Hsu, K.H.; Ko, Y.H.; Lee, Y.S. Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum. Genet 2002, 110, 57-63.
46. Jap, T.S.; Wu, Y.C.; Tso, Y.C.; Chiu, C.Y. A novel mutation in the intron 1 splice donor site of the cholesterol ester transfer protein (CETP) gene as a cause of hyperalphalipoproteinemia. Metabolism 2002, 51, 394-397.
47. Song, G.J.; Han, G.-H.; Chae, J.J.; Namkoong, Y.; Lee, H.K.; Park, Y.B.; Lee, C.C. The effect of the cholesterol ester transfer protein gene and environmental factors on the plasma high density lipoprotein cholesterol levels in the Korean population. Mol. Cells 1997, 7, 615-619.
48. Thu, N.N.; Mai, T.T.; Ohmori, R.; Kuroki, M.; Van Chuyen, N.; Hung, N.T.; Kawakami, M.; Kondo, K. Effect of the cholesteryl ester transfer protein genotypes on plasma lipid and lipoprotein levels in Vietnamese children. Pediatr. Res. 2005, 58, 1249-1253.
49. Plengpanich, W.; Siriwong, S.; Khovidhunkit, W. Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia. Metabolism 2009, 58, 1178-1184.
50. Thompson, J.F.; Reynolds, J.M.; Williams, S.P.; Wood, L.S.; Paciga, S.A.; Lloyd, D.B. Frequency and function of CETP variants among individuals of Asian ancestry. Atherosclerosis 2009, 202, 241-247.
51. Arkhipova, N.S.; Ar'ev, A.L.; Popova, E.K.; Grigor'eva, L.V.; Kozina, L.S. Association of polymorphism of angiotensin-converting enzyme gene I/D and D442G cholesteryl ester transfer protein gene with risk factors for atherosclerosis among elderly and senile patients with coronary heart disease in the Republic Sakha (Yakutia) (original Russian text is published in Uspekhi gerontologii vol 26: 76-81 in 2013). Adv. Gerontol. 2013, 3, 277-281.
52. Ma, Y.Q.; Thomas, G.N.; Critchley, J.A.; Chan, J.C.; Lee, Z.S.; Tomlinson, B. Identification of the intron 14 splicing defect of the cholesteryl ester transfer protein gene in Hong Kong Chinese. Clin. Genet. 2001, 59, 287-289.
53. Dixit, M.; Bhattacharya, S.; Mittal, B. Association of CETP TaqI and APOE polymorphisms with type ii diabetes mellitus in North Indians: A case control study. BMC Endocr. Disord. 2005, 5, doi:10.1186/1472-6823-5-7.
54. Teh, E.M.; Dolphin, P.J.; Breckenridge, W.C.; Tan, M.H. Human plasma CETP deficiency: Identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America. J. Lipid Res. 1998, 39, 442-456.
55. Hill, S.A.; Nazir, D.J.; Jayaratne, P.; Bamford, K.S.; McQueen, M.J. Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population. Clin. Biochem. 1997, 30, 413-418.
56. van der Steeg, W.A.; Hovingh, G.K.; Klerkx, A.H.; Hutten, B.A.; Nootenboom, I.C.; Levels, J.H.; van Tol, A.; Dallinga-Thie, G.M.; Zwinderman, A.H.; Kastelein, J.J.; et al. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians. J. Lipid Res. 2007, 48, 674-682.
57. Rhyne, J.; Ryan, M.J.; White, C.; Chimonas, T.; Miller, M. The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. J. Mol. Med. (Berl) 2006, 84, 647-650.
58. Cefalu, A.B.; Noto, D.; Magnolo, L.; Pinotti, E.; Gomaraschi, M.; Martini, S.; Vigna, G.B.; Calabresi, L.; Tarugi, P.; Averna, M.R. Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia. Atherosclerosis 2009, 204, 202-207.
59. Calabresi, L.; Nilsson, P.; Pinotti, E.; Gomaraschi, M.; Favari, E.; Adorni, M.P.; Bernini, F.; Sirtori, C.R.; Calandra, S.; Franceschini, G.; et al. A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred. Atherosclerosis 2009, 205, 506-511.
60. Chantepie, S.; Bochem, A.E.; Chapman, M.J.; Hovingh, G.K.; Kontush, A. High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: Maintenance of antioxidative activity. PLoS ONE 2012, 7, e49336.
61. Thompson, A.; Di Angelantonio, E.; Sarwar, N.; Erqou, S.; Saleheen, D.; Dullaart, R.P.; Keavney, B.; Ye, Z.; Danesh, J. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 2008, 299, 2777-2788.
62. Inazu, A.; Brown, M.L.; Hesler, C.B.; Agellon, L.B.; Koizumi, J.; Takata, K.; Maruhama, Y.; Mabuchi, H.; Tall, A.R. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. New Eng. J. Med. 1990, 323, 1234-1238.
63. Yamashita, S.; Hui, D.Y.; Sprecher, D.L.; Matsuzawa, Y.; Sakai, N.; Tarui, S.; Kaplan, D.; Wetterau, J.R.; Harmony, J.A. Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect. Biochem. Biophys. Res. Commun. 1990, 170, 1346-1351.
64. Yamashita, S.; Hui, D.Y.; Wetterau, J.R.; Sprecher, D.L.; Harmony, J.A.K.; Sakai, N.; Matsuzawa, Y.; Tarui, S. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficeiency: Plasma CETP regulated high-density lipoprotein concentration and composition. Metabolism 1991, 40, 756-763.
65. Sakai, N.; Matsuzawa, Y.; Hirano, K.; Yamashita, S.; Nozaki, S.; Ueyama, Y.; Kubo, M.; Tarui, S. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency. Arterioscler. Thromb. 1991, 11, 71-79.
66. Bisgaier, C.L.; Siebenkas, M.V.; Brown, M.L.; Inazu, A.; Koizumi, J.; Mabuchi, H.; Tall, A.R. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin. J. Lipid Res. 1991, 32, 21-33.
67. Yamashita, S.; Sprecher, D.L.; Sakai, N.; Matsuzawa, Y.; Tarui, S.; Hui, D.Y. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J. Clin. Invest. 1990, 86, 688-695.
68. Moriyama, Y.; Okamura, T.; Inazu, A.; Doi, M.; Iso, H.; Mouri, Y.; Ishikawa, Y.; Suzuki, H.; Iida, M.; Koizumi, J.; et al. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev. Med. 1998, 27, 659-667.
69. Curb, J.D.; Abbott, R.D.; Rodriguez, B.L.; Masaki, K.; Chen, R.; Sharp, D.S.; Tall, A.R. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J. Lipid Res. 2004, 45, 948-953.
70. Yamashita, S.; Sakai, N.; Hirano, K.; Arai, T.; Ishigami, M.; Maruyama, T.; Matsuzawa, Y. Molecular genetics of plasma cholesteryl ester transfer protein. Curr. Opin. Lipidol. 1997, 8, 101-110.
71. Nissen, S.E.; Tardif, J.C.; Nicholls, S.J.; Revkin, J.H.; Shear, C.L.; Duggan, W.T.; Ruzyllo, W.; Bachinsky, W.B.; Lasala, G.P.; Tuzcu, E.M. Effect of torcetrapib on the progression of coronary atherosclerosis. N. Engl. J. Med. 2007, 356, 1304-1316.
72. Schwartz, G.G.; Olsson, A.G.; Abt, M.; Ballantyne, C.M.; Barter, P.J.; Brumm, J.; Chaitman, B.R.; Holme, I.M.; Kallend, D.; Leiter, L.A.; et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N. Engl. J. Med. 2012, 367, 2089-2099.
73. Kit, B.K.; Carroll, M.D.; Lacher, D.A.; Sorlie, P.D.; DeJesus, J.M.; Ogden, C. Trends in serum lipids among us youths aged 6 to 19 years, 1988-2010. JAMA 2012, 308, 591-600.
74. FAOSTAT (Food and Agriculture Organization of The United Nations, Statistics Division). Available online: http://faostat3.fao.org/download/FB/*/E (accessed on 1 January 2012).